Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus-Eluting Stent: Real-World Outcomes From the Multicenter Prospective e-Ultimaster Registry
- PMID: 31787055
- PMCID: PMC6912975
- DOI: 10.1161/JAHA.119.013786
Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus-Eluting Stent: Real-World Outcomes From the Multicenter Prospective e-Ultimaster Registry
Erratum in
-
Correction to: Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus-Eluting Stent: Real-World Outcomes From the Multicenter Prospective e-Ultimaster Registry.J Am Heart Assoc. 2020 Jun 16;9(12):e014539. doi: 10.1161/JAHA.119.014539. Epub 2020 Jun 9. J Am Heart Assoc. 2020. PMID: 32515256 Free PMC article. No abstract available.
Abstract
Background Guidelines recommend heart team discussion and coronary artery bypass graft consideration in patients with proximal left anterior descending (LAD) artery stenosis. Evidence suggests that outcomes of proximal LAD angioplasty might not differ from treatment of nonproximal LAD locations. We aim to determine clinical outcomes of patients undergoing percutaneous coronary intervention in the proximal LAD segment in comparison with nonproximal LAD angioplasty, using a thin-strut drug-eluting stent. Methods and Results In this analysis of the e-Ultimaster registry, patients undergoing angioplasty in the proximal LAD territory were compared with those treated in nonproximal LAD locations. Multivariate analysis and propensity score were used to adjust for differences among the groups. The primary outcome was target lesion failure: a composite of cardiac death, target-lesion-related myocardial infarction, and/or clinically driven target lesion revascularization at 1-year follow-up. Of the 17 805 patients (mean age, 64.2±11; 76% male), 5452 (30.6%) underwent proximal LAD and 12 353 (69.4%) nonproximal LAD percutaneous coronary intervention. Patients in the proximal LAD group had more multivessel disease (48.7% versus 43.5%; P<0.001) and 2-fold more bifurcations lesions (18.8% versus 9.2%; P<0.0001). After propensity-weighted adjustment, target lesion failure did not differ between the groups (3.3% versus 2.9%; P=0.17 for proximal LAD versus nonproximal LAD angioplasty, respectively). In multivariate analysis, proximal LAD treatment was not an independent predictor of target lesion failure (odds ratio, 1.07; 95% CI, 0.88-1.31; P=0.48). Conclusions At 1-year follow-up, patients had similar clinical outcomes independent of stenting location, questioning whether proximal LAD treatment should be regarded differently from stenting in any other coronary artery territory.
Keywords: catheterization outcomes; proximal left anterior descending angioplasty; stenting.
Figures


Similar articles
-
Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily clinical practice: Propensity matched one-year results from interventional cardiology network registry.Catheter Cardiovasc Interv. 2019 Jun 1;93(7):E362-E368. doi: 10.1002/ccd.27919. Epub 2018 Oct 8. Catheter Cardiovasc Interv. 2019. PMID: 30298545
-
Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT Trial.JACC Cardiovasc Interv. 2017 Mar 27;10(6):548-556. doi: 10.1016/j.jcin.2016.12.028. JACC Cardiovasc Interv. 2017. PMID: 28335893 Clinical Trial.
-
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.JACC Cardiovasc Interv. 2020 Apr 13;13(7):820-830. doi: 10.1016/j.jcin.2019.11.023. JACC Cardiovasc Interv. 2020. PMID: 32273094
-
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.Circ Cardiovasc Interv. 2018 Oct;11(10):e007331. doi: 10.1161/CIRCINTERVENTIONS.118.007331. Circ Cardiovasc Interv. 2018. PMID: 30354631 Clinical Trial.
-
Revascularization for Left Anterior Descending Artery Stenosis: A Review of the Evidence That Supports Practice.Cardiol Rev. 2016 May-Jun;24(3):136-40. doi: 10.1097/CRD.0000000000000097. Cardiol Rev. 2016. PMID: 26751264 Review.
Cited by
-
Prognosis of PCI in AMI setting in the elderly population: Outcomes from the multicenter prospective e-ULTIMASTER registry.Clin Cardiol. 2022 Dec;45(12):1211-1219. doi: 10.1002/clc.23902. Epub 2022 Sep 7. Clin Cardiol. 2022. PMID: 36072999 Free PMC article.
-
Treatment of Ostial Right Coronary Artery Narrowings: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry.J Soc Cardiovasc Angiogr Interv. 2023 Feb 25;2(3):100604. doi: 10.1016/j.jscai.2023.100604. eCollection 2023 May-Jun. J Soc Cardiovasc Angiogr Interv. 2023. PMID: 39130698 Free PMC article.
-
Efficacy and Safety of Sirolimus-Eluting Stent With Biodegradable Polymer Ultimaster™ in Unselected Korean Population: A Multicenter, Prospective, Observational Study From Korean Multicenter Ultimaster Registry.Korean Circ J. 2024 Jun;54(6):339-350. doi: 10.4070/kcj.2024.0023. Epub 2024 Apr 22. Korean Circ J. 2024. PMID: 38767441 Free PMC article.
-
Prognosis of PCI in the Older Adult Population: Outcomes From the Multicenter Prospective e-ULTIMASTER Registry.J Soc Cardiovasc Angiogr Interv. 2022 Aug 24;1(5):100442. doi: 10.1016/j.jscai.2022.100442. eCollection 2022 Sep-Oct. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39131453 Free PMC article.
-
Mortality after multivessel revascularisation involving the proximal left anterior descending artery.Heart. 2022 Oct 28;108(22):1784-1791. doi: 10.1136/heartjnl-2022-320934. Heart. 2022. PMID: 35732441 Free PMC article. Clinical Trial.
References
-
- Kinnaird T, Kwok CS, Narain A, Butler R, Ossei‐Gerning N, Ludman P, Moat N, Anderson R, Mamas MA. Meta‐analysis of percutaneous coronary intervention with drug‐eluting stent versus coronary artery bypass grafting for isolated proximal left anterior descending coronary disease. Am J Cardiol. 2016;118:1171–1177. - PubMed
-
- Jaffery Z, Kowalski M, Weaver WD, Khanal S. A meta‐analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. Eur J Cardiothorac Surg. 2007;31:691–697. - PubMed
-
- Kapoor JR, Gienger AL, Ardehali R, Varghese R, Perez MV, Sundaram V, McDonald KM, Owens DK, Hlatky MA, Bravata DM. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. JACC Cardiovasc Interv. 2008;1:483–491. - PubMed
-
- Neumann FJ, Sousa‐Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group . 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40:87–165. - PubMed
-
- Kerner A, Abergel E, Halabi M, Soni A, Danzi GB, Yalonestky S, Spaepen E, Paunovic D, Nikolsky E, Beyar R, Roguin A. Should proximal LAD be treated differently? Insights from a large DES stent registry. Cardiovasc Revasc Med. 2013;14:325–332. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical